| Identification | Back Directory | [Name]
clopenthixol | [CAS]
982-24-1 | [Synonyms]
N-746
AY-62021
Sordinol
NSC-64087
Neo-ciatyl
Aids115500
Aids-115500
clopenthixol
CHLORPENTHIXOL
clopenthixol USP/EP/BP
Zuclopenthixol (cis+trans)
Zuclopenthixol (Clopenthixol)
Zuclopenthixol (cis+trans) in methanol
Zuclopenthixol (Clopenthixol) (Mixture of Z and E Isomers)
4-[3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl]-1-piperazineethanol
1-Piperazineethanol, 4-(3-(2-chloro-9H-thioxanthen-9-ylidene)propyl)-
2-(4-(3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethanol
ClopenthixolQ: What is
Clopenthixol Q: What is the CAS Number of
Clopenthixol Q: What is the storage condition of
Clopenthixol | [EINECS(EC#)]
213-566-0 | [Molecular Formula]
C22H25ClN2OS | [MDL Number]
MFCD00866662 | [MOL File]
982-24-1.mol | [Molecular Weight]
400.971 |
| Hazard Information | Back Directory | [Chemical Properties]
Colorless slurry. Freely soluble in methanol, poorly soluble in ether.
cis(Z)-configuration: [53772-83-1]. Crystallizes, melting point 84-85°C.
Clopenthixol dihydrochloride: C22H25C1N2OS?2HCl. [633-59-0]. Crystallizes from ethanol, melting point 250-260°C (decomposition). Very soluble in water, poorly soluble in alcohol, and practically insoluble in other organic solvents. Acute toxicity LD50 male mouse (mg/kg): 111 intravenous injection.
cis(Z)-dihydrochloride: [58045-23-1]. Crystallizes, melting point 250-260°C (decomposition). Acute toxicity LD50 male mouse (mg/kg): 105 intravenous injection. | [Originator]
Ciatyl,Tropon,W. Germany,1961 | [Uses]
Antipsychotic. | [Definition]
ChEBI: A thioxanthene derivative having a chloro substituent at the 2-position and an alkylidene group at the 10-position with undefined double bond stereochemistry. | [Manufacturing Process]
A mixture of 31 5 g (0.1 mol) of 2-chloro-9-(3'-dimethylaminopropylidene)-
thiaxanthene (MP 97°C) and 100 g of N-(β-hydroxyethyl)piperazine is heated
to 130°C and boiled under reflux at this temperature for 48 hours. After
cooling,the excess of N-(β-hydroxyethyl)piperazine is evaporated in vacuo,
and the residue is dissolved in ether. The ether phase is washed with water
and extracted with dilute acetic acid, and 2-chloro-9-[3'-N-(N'-β-
hydroxyethyl)piperazinylpropylidene]-thiaxanthene separated from the
aqueous acetic acid solution by addition of dilute sodium hydroxide solution to
basic reaction. The free base is extracted with ether, the ether phase dried
over potassium carbonate, the ether evaporated and the residue dissolved in
absolute ethanol. By complete neutralization of the ethanolic solution with a
solution of dry hydrogen chloride in absolute ethanol, the dihydrochloride of 2-
chloro-9-[3'-N-(N'-β-hydroxyethyl)piperazinylpropylidene]-thiaxanthene is
produced and crystallizes out as a white substance melting at about 250°C to
260°C with decomposition. The yield is 32 g. | [Therapeutic Function]
Antipsychotic |
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Website: |
www.lgmpharma.com |
|